Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

DBV Submits VIASKIN Peanut Patch for FDA Approval Following Phase 3 Success

Aquestive Resubmits Needle-Free Sublingual Epinephrine to FDA for Approval

Potential Breakthrough for Celiac Disease: Teva Antibody Significantly Reduces Gluten-Induced Gut Damage

Rare Antibodies Could Lead to First Targeted Treatment for Alpha-Gal Syndrome

Another Potential Food Allergy Treatment is Snapped Up by Big Pharma

Toothpaste Therapy for Food Allergies Takes Another Step Forward

DBV Optimistic Viaskin Peanut “Patch” Therapy has Path to Approval After...

Nanoparticle Shows Promise for Treatment of Severe Allergies

Is Your Covid Vaccine Venue Prepared to Handle Rare, Life-Threatening Reactions?

DBV, Developers of Patch Therapies for Allergies to Peanuts, Milk and...

NIH Rushing to Find Cause of Rare Allergic Reactions to COVID-19...

What We Know About PEG, Suspected as the Cause of Reactions...

FDA Authorizes Moderna Vaccine, Another Pfizer Vaccine Recipient Has Allergic Reaction

Moderna COVID-19 Vaccine List of Ingredients

Healthcare Worker in Alaska Suffers Anaphylactic Reaction After Pfizer COVID-19 Immunization

Follow Us

Your School On Our Map

Put Your School on the Map